The Correlation Between CYP19 Levels, VAS of Dysmenorrhea, and the Grading Score ASRM of Endometriosis

Fatimah Usman; Muhammad Komarul Hakim; Heriyadi Manan; Mgs. Irsan Saleh

doi:10.24198/obgynia/v6.n2.503

The Correlation Between CYP19 Levels, VAS of Dysmenorrhea, and the Grading Score ASRM of Endometriosis

Fatimah Usman,^(1*) Muhammad Komarul Hakim,⁽²⁾ Heriyadi Manan,⁽³⁾ Mgs. Irsan Saleh,⁽⁴⁾

(1) Department of Obstetrics and Gynevcology, Faculty of Medicine Sriwijaya University, Dr. Moh. Hoesin Hospital Palembang Indonesia
(2) Department of Obstetrics and Gynecology, Faculty of Medicine Sriwijaya University, Dr. Moh. Hoesin Hospital Palembang Indonesia
(3) Department of Obstetrics and Gynevcology, Faculty of Medicine Sriwijaya University, Dr. Moh. Hoesin Hospital Palembang Indonesia
(4) Department of Biomedical Engineering, Faculty of Medicine Sriwijaya University, Dr. Moh. Hoesin Hospital Palembang Indonesia
(*) Corresponding Author

Abstract

Objective: We aim to assess the correlation between the CYP19 level, the visual analogue scale (VAS) pain and endometriosis American Society for Reproductive Medicine (ASRM) grading scale.
Method: An observational analytic study with a cross–sectional design was conducted at the Obstetrics/Gynecology Department, RSUP Dr. Moh Hoesin Palembang, Laboratory of Biomedical and Biomolecular of the Faculty of Medicine, Universitas Sriwijaya from July–December 2022. Subjects who were diagnosed with endometriosis and met the inclusion and exclusion criteria underwent a histopathological examination to measure the degree of disease according to ASRM. Using the same sample, the CYP19 levels were assessed by enzyme linked immunosorbent assay (ELISA). Univariate and bivariate statistical analyses were performed to see the correlation.
Results: This study involved 37 subjects aged 20–48 (Mean: 32 years). We found there was a significant correlation between the degree of VAS score and ASRM grading (p<0.001). In addition, although CYP19 expression was found in ectopic endometrial tissue, there was no significant correlation between the level of CYP19 expression in the tissue and the VAS score dysmenorrhea (p= 0,618) and ASRM grading (p=0.604).
Conclusion: There is no significant correlation between CYP19 levels and the degree of pain in VAS or ASRM grading in patients.

Hubungan Kadar CYP19, Visual Analogue Score (VAS) Dismenorea, dan Grading Score American Society for Reproductive Medicine (ASRM) Endometriosis

Abstrak
Tujuan: Penelitian ini bertujuan untuk menilai hubungan kadar CYP19, skala nyeri visual analogue scale (VAS) dan grading berdasarkan American Society for Reproductive Medicine (ASRM) pada pasien endometriosis.
Metode: Sebuah studi analitik observasional dengan rancangan cross–sectional dilakukan di Bagian/KSM Obstetri Ginekologi, RSUP Dr. Moh Hoesin Palembang dan Laboratorium Biomedis dan Biomolekuler Fakultas Kedokteran Universitas Sriwijaya, pada periode Juli–Desember 2022. Subjek penelitian yang terdiagnosis endometriosis dan memenuhi kriteria inklusi dan eksklusi, dilanjutkan pemeriksaan histopatologis untuk mengukur derajat penyakit sesuai rASRM. Dengan menggunakan sampel yang sama dilakukan penilaian kadar CYP19 melalui pemeriksaan enzyme linked immunosorbent assay (ELISA). Analisis statistik univariat dan bivariat dilakukan untuk melihat hubungan tersebut.
Hasil: Penelitian ini melibatkan 37 subjek dengan rentang usia 20–48 (Median: 32 tahun). Pada penelitian, terdapat hubungan yang bermakna antara derajat nyeri VAS endometriosis terhadap derajat endometriosis (p<0,001). Selain itu, walaupun ditemukan adanya ekspresi CYP19 pada jaringan endometrium ektopik, namun tidak terdapat hubungan yang bermakna antara tingkat kadar CYP19 pada jaringan dengan derajat VAS score dismenorea (p=0,618) dan derajat ASRM endometriosis (p=0,604).
Kesimpulan: Tidak terdapat hubungan bermakna antara kadar CYP19 dengan derajat nyeri VAS maupun derajat ASRM endometriosis pada pasien.

Kata kunci: ASRM, Kadar CYP19, Endometriosis

Keywords

Endometriosis, CYP19, ASRM

Full Text:

PDF

References

Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Viganò P. Endometriosis. Nat Rev Dis Prim. 2018;4(1).

DeCherney A, Muse K. Endometriosis. Dalam: DeCherney A, Nathan L, Goodwin M, Laufer N, editor. Lange’s current diagnosis & treatment obstetrics & gynecology. 12th ed. Philadelphia: McGraw-Hill; 2019.

Parasar P, Ozcan P, Terry KL. Endometriosis: Epidemiology, diagnosis and clinical management. Curr Obstet Gynecol Rep. 2017;6(1):34–41.

Berek JS. Berek & Novak’s Gynecology. 16th ed. Philadelphia: Lippincott Williams & Wilkins; 2019.

Johnson NP, Hummelshoj L, Adamson GD, Keckstein J, Taylor HS, Abrao MS, et al. World endometriosis society consensus on the classification of endometriosis. Hum Reprod. 2017;32(2):315–24.

Fritz M, Speroff L. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2011. 1221 hal.

Richard O. Burney, M.D. MS, Linda C. Giudice, M.D. PD. Pathogenesis and pathophysiology of endometriosis. 2013;98(3).

Acien P, Velasco I, Gutierrez M, Beltran M. Aromaterase expression in endometriotic tissues and its relationship to clinical and analytical findings. Fertil Steril. 2007;8(1):1–7.

Maia H, Haddad C, Casoy J. Correlation between aromatase expression in the eutopic endometrium of symptomatic patients and the presence of endometriosis. Int J Womens Health. 2012;4(1):61–5.

Slopien E, Meczekalski B. Aromatase inhibitors in the treatment of endometriosis. Prz Menopauzalmy. 2016;15(1):43–7.

Bulun S. Aromatase and endometriosis. Sem Reprod Med. 2004;22(1):45–50.

Slopien E, Meczekalski B. Aromatase inhibitors in the treatment of endometriosis. Prz Menopauzalmy. 2016;15(1):43–7.

Seracchioli R, Mabrouk M, Guerrini M, Manuzzi L, Savelli L, Frascà C, et al. Dyschezia and posterior deep infiltrating endometriosis: Analysis of 360 cases. J Minim Invasive Gynecol. 2008;15(6).

Maddern J, Grundy L, Castro J, Brierley SM. Pain in endometriosis. Fertil Steril. 2020;14(10):1–16.

Velasco I, Rueda J, Acién P. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Mol Hum Reprod. 2006;12(6):377–81.

Bulun S, Zeiton K, Takayama, Noble L. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocr Relat Cancer. 1999;6:293–301.

Fowler JM, Ramirez N, Cohn DE, Kelbick N, Pavelka J, Ben-Shachar I, et al. Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: Tissue microarray analysis. Am J Obstet Gynecol. 2005;192(4):1262–71.

HIFERI. Panduan Nasional Pelayanan Kedokteran Nyeri Endometriosis. Jakarta: POGI-HIFERI; 2013.

American Society for Reproductive Medicine. Endometriosis: A Guide for patients revised. 2012.

Mala H, Haddad C, Coelho G, Casoy J. Role of inflammation and aromatase expression in the eutopic endometrium and its relationship with the developmental of endometriosis. Women Heal. 2012;8(6):647–58.

Stratton P, Berkley KJ. Chronic pelvic pain and endometriosis: Translational evidence of the relationship and implications. Hum Reprod Update. 2011;17(3):327–46.

DOI: http://dx.doi.org/10.24198/obgynia/v6.n2.503